epigallocatechin gallate has been researched along with Atrophy in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Fang, L; Huang, J; Ou, K; Wang, C; Wang, Q; Xia, S; Zhang, S | 1 |
Bellmann-Strobl, J; Brandt, AU; Chien, C; Dörr, J; Klumbies, K; Lorenz, M; Paul, F; Rust, R; Scheel, M; Wernecke, KD; Wuerfel, J; Zimmermann, H | 1 |
1 trial(s) available for epigallocatechin gallate and Atrophy
Article | Year |
---|---|
Epigallocatechin Gallate in Progressive MS: A Randomized, Placebo-Controlled Trial.
Topics: Administration, Oral; Adult; Atrophy; Brain; Catechin; Disease Progression; Double-Blind Method; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Outcome Assessment, Health Care; Random Allocation | 2021 |
1 other study(ies) available for epigallocatechin gallate and Atrophy
Article | Year |
---|---|
EGCG exposure during pregnancy affects uterine histomorphology in F1 female mice and the underlying mechanisms.
Topics: Animals; Atrophy; Catechin; Female; Fibrosis; Inflammation; Mice; Mice, Inbred C57BL; Pregnancy; Tea | 2022 |